Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02949921 · ClinicalTrials.gov registry record · NA
Radiological Evaluation of Radiesse Implantation in the Hands
A NA study of Volume Loss in the Dorsum of the Hand, sponsored by Merz North America.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT02949921: Completed NA study of Volume Loss in the Dorsum of the Hand, sponsored by Merz North America.
NCT02949921 is a NA study of Volume Loss in the Dorsum of the Hand that has completed, run by Merz North America. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02949921, a NA study of Volume Loss in the Dorsum of the Hand, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to provide a preliminary assessment of the radiographic appearance of Radiesse material that has been injected into the dorsum of the hands.
Primary Outcome
Obscuration was defined as any post-treatment hand x-ray that at least 1 of the 2 blinded radiologist interpreted as Radiesse obscuring bones.
Conditions Studied
Interventions
- DEVICE Radiesse injectable implant and 2% lidocaine HCL
Study Locations (1)
California
- Merz Investigative Site #0010358 - Vista
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-12-01 |
| Est. Completion | 2018-01-02 |
| Phase | NA |
What the finished NCT02949921 record still lists
NCT02949921 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Volume Loss in the Dorsum of the Hand appearing as the primary indexed condition, and to 1 intervention - of which Radiesse injectable implant and 2% lidocaine HCL is the first listed.
NCT02949921 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02949921 about?
NCT02949921 is a clinical study titled "Radiological Evaluation of Radiesse Implantation in the Hands". The objective of this study is to provide a preliminary assessment of the radiographic appearance of Radiesse material that has been injected into the dorsum of the hands.
What is the current status of trial NCT02949921?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2015-12-01. Estimated completion is 2018-01-02.
What conditions does trial NCT02949921 study?
This clinical trial studies the following conditions: Volume Loss in the Dorsum of the Hand.
What interventions are being tested in trial NCT02949921?
The interventions under investigation include: Radiesse injectable implant and 2% lidocaine HCL (DEVICE).
Who is sponsoring clinical trial NCT02949921?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02949921 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Volume Loss in the Dorsum of the Hand
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02949921's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI